MedTrace Logo

Joint and Hematologic Disorders of Noonan Syndrome: French Descriptive Cross-sectional Study

NCT06550635 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 71

Last updated 2024-08-13

No results posted yet for this study

Summary

Noonan's syndrome is a rare genetic disease, estimated to be between 1: 1000 to 1: 2500 and characterized by cardiothoracic malformations, sometimes mental retardation, but also by hematologic abnormalities and joint involvement. These are poorly described in the literature. The aim of this work is therefore to describe the frequency and type of these manifestations in the French pediatric population and to compare patients with and without these disorders.

Conditions

  • Noonan Syndrome

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Eligibility

Min Age
0 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-02
Primary Completion
2020-03-28
Completion
2020-03-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06550635 on ClinicalTrials.gov